Bio-Rad Labs Inc. A buy Citigroup Inc.
Start price
01.10.24
/
50%
€299.30
Target price
01.10.25
€361.20
Performance (%)
-16.17%
End price
02.10.25
€250.90
Summary
This prediction ended on 02.10.25 with a price of €250.90. The prediction for Bio-Rad Labs Inc. A disappointed with a performance of -16.17%. Citigroup_Inc_ has a follow-up prediction for Bio-Rad Labs Inc. A where he still thinks Bio-Rad Labs Inc. A is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | -3.715% | -3.715% | -11.547% |
| iShares Core DAX® | -0.998% | 0.151% | 24.921% |
| iShares Nasdaq 100 | 2.834% | 6.588% | 22.858% |
| iShares Nikkei 225® | 5.533% | 14.305% | 27.683% |
| iShares S&P 500 | 1.544% | 4.190% | 14.269% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $400.00 price target on the stock, up previously from $350.00.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€262.00
30.10.25
30.10.25
€322.88
30.10.26
30.10.26
0.00%
31.10.25
31.10.25
Stopped prediction by Citigroup_Inc_ for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€329.60
31.10.24
31.10.24
€413.33
31.10.25
31.10.25
-15.87%
01.11.25
01.11.25